401 related articles for article (PubMed ID: 17620046)
1. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
Grant SF; Hakonarson H
Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
[TBL] [Abstract][Full Text] [Related]
2. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?
Lango H; Weedon MN
J Intern Med; 2008 Jan; 263(1):16-27. PubMed ID: 18088250
[TBL] [Abstract][Full Text] [Related]
3. Planning a genome-wide association study: points to consider.
Hakonarson H; Grant SF
Ann Med; 2011; 43(6):451-60. PubMed ID: 21595511
[TBL] [Abstract][Full Text] [Related]
4. The success of the genome-wide association approach: a brief story of a long struggle.
Seng KC; Seng CK
Eur J Hum Genet; 2008 May; 16(5):554-64. PubMed ID: 18285837
[TBL] [Abstract][Full Text] [Related]
5. Advances in the development of genetic markers for the diagnosis of disease and drug response.
Halapi E; Hakonarson H
Expert Rev Mol Diagn; 2002 Sep; 2(5):411-21. PubMed ID: 12271813
[TBL] [Abstract][Full Text] [Related]
6. Genome-based prediction of common diseases: advances and prospects.
Janssens AC; van Duijn CM
Hum Mol Genet; 2008 Oct; 17(R2):R166-73. PubMed ID: 18852206
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancer.
Kronenberg F
Exp Gerontol; 2008 Jan; 43(1):39-43. PubMed ID: 17967522
[TBL] [Abstract][Full Text] [Related]
8. Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery.
Hutcheson HB; Lautenberger JA; Nelson GW; Pontius JU; Kessing BD; Winkler CA; Smith MW; Johnson R; Stephens R; Phair J; Goedert JJ; Donfield S; O'Brien SJ
Vaccine; 2008 Jun; 26(24):2951-65. PubMed ID: 18325640
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
Nguyen TV; Center JR; Eisman JA
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association studies of cancer.
Jorgenson E; Witte JS
Future Oncol; 2007 Aug; 3(4):419-27. PubMed ID: 17661717
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
12. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
13. A gene-centric approach to genome-wide association studies.
Jorgenson E; Witte JS
Nat Rev Genet; 2006 Nov; 7(11):885-91. PubMed ID: 17047687
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association studies in atherothrombosis.
Lotta LA
Eur J Intern Med; 2010 Apr; 21(2):74-8. PubMed ID: 20206874
[TBL] [Abstract][Full Text] [Related]
15. Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors.
Reinhard W; Stark K; Neureuther K; Sedlacek K; Fischer M; Baessler A; Weber S; Kaess B; Wiedmann S; Erdmann J; Lieb W; Jeron A; Riegger G; Hengstenberg C
Int J Mol Med; 2008 Aug; 22(2):165-74. PubMed ID: 18636169
[TBL] [Abstract][Full Text] [Related]
16. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.
Hamsten A; Eriksson P
J Intern Med; 2008 May; 263(5):538-52. PubMed ID: 18410597
[TBL] [Abstract][Full Text] [Related]
17. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
18. New approaches to understanding the genetics of asthma.
Meyers DA
Immunol Allergy Clin North Am; 2005 Nov; 25(4):743-55. PubMed ID: 16257636
[TBL] [Abstract][Full Text] [Related]
19. Approaches to the identification of susceptibility genes.
Collins A
Parasite Immunol; 2009 May; 31(5):225-33. PubMed ID: 19388944
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and nutrigenomics: synergies and differences.
Ghosh D; Skinner MA; Laing WA
Eur J Clin Nutr; 2007 May; 61(5):567-74. PubMed ID: 17213870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
